Concordia Healthcare (CXRX) Trades Lower in Sympathy with Peer Valeant Pharma (VRX)
- Stocks face worst month since September, yen swings after BoJ
- Microsoft fiscal Q3 results top estimates as AI revolution spurs cloud growth
- Alphabet stock surges 11% to record high on Q1 earnings beat, first-ever dividend
- Intel slides in afterhours trading as Q1 revenue misses, Q2 outlook falls short
- Oil prices on track to snap two-week losing streak
- Rubrik (RBRK) Prices Upsized 23.5M Share IPO at $32/sh
- Union Pacific beats profit estimates on stronger pricing, resumes share buyback
- IBM tumbles on soft Q1 revenue; announces HashiCorp $6.4bn acquisition
- Hertz Global (HTZ) misses earnings expectations as fleet costs weigh
- Teladoc (TDOC) Misses Q1 EPS by 3c, offers outlook
- After-hours movers: Alphabet, Microsoft, Snap, Intel, and more
- Midday movers: Meta, IBM, Caterpillar fall; Chipotle rises
- After-hours movers: Meta, Ford, IBM, ServiceNow and more
- Midday movers: Tesla, Boeing rise; Uber, Old Dominion Freight fall
- After-hours movers: Tesla, Texas Instruments, Seagate, Visa and more
Valeant Pharma (VRX): This Isn't Just Headline Risk - Mizuho
August 11, 2016 8:08 AM EDTMizuho Securities analyst, Irina Koffler, reiterated her Underperform rating on shares of Valeant Pharmaceuticals (NYSE: VRX) and highlighted the importance of last night's WSJ report that VRX is under criminal investigation by the U.S. attorney's office. The charges are for mail and wire fraud and obscuring the company's real... More
Valeant Pharma (VRX) Issues Statement on SDNY Investigation; Will Not Comment on Rumors
August 11, 2016 6:28 AM EDTValeant Pharmaceuticals International, Inc. (NYSE: VRX) issued the following statement regarding the ongoing investigation being conducted by the U.S. Attorney's Office for the Southern District of New York:
"Valeant previously disclosed in October 2015 that the United States Attorney's Office for the Southern... More
Valeant Pharma (VRX) Under Criminal Investigation - WSJ
August 10, 2016 6:39 PM EDT(Updated - August 11, 2016 6:28 AM EDT)
Valeant Pharma (NYSE: VRX) shares are dropping after-hours Wednesday following reports from the Wall Street Journal the company is under criminal investigation.
Federal prosecutors are investigating if the company defrauded insurance companies by hiding its ties to mail-order pharmacy Philidor Rx... More